Avandia and the future of diabetes care
The FDA will soon hold a public hearing about the safety of Avandia, a widely-used diabetes drug. We'll talk about how the drug is used, what the alternatives are, and how the health care system is prepared for the millions of Americans who will develop type 2 diabetes in coming years.
- Steven Nissen, MD: Author of the original Avandia study and chairman of the department of cardiovascular medicine at the Cleveland Clinic.
- Richard Bergenstal, MD: President of the Medicine and Science of the American Diabetes Association, Executive Director of the International Diabetes Center at Park Nicollet, Clinical Professor Department of Medicine University of Minnesota.
- Francine Kaufman, MD: Vice President of Global Medical Affairs for Diabetes, Medtronic, and Professor of Pediatrics at the Keck School of Medicine of the University of Southern California.